Basic Principles and Neurosurgical Applications of Positron Emission Tomography

Role of neuroimaging in the management of seizure disorders

Neuroimaging is one of the most important advances made in the past decade in the management of seizure disorders. Magnetic resonance imaging (MRI) has increased substantially the ability to detect causes of seizure disorders, to plan medical or surgical therapy, and to prognosticate the outcome of disorders and therapy. However, MRI must be performed with techniques that will maximize the detection of potentially epileptogenic lesions, especially in candidates for epilepsy surgery. Functional imaging has an established role in evaluating patients for epilepsy surgery. It is relied on when results from standard diagnostic methods, such as clinical information, electroencephalography, and MRI, are insufficient to localize the seizure focus. Also, functional imaging is a reportedly reliable alternative to invasive methods for identifying language, memory, and sensorimotor areas of the cerebral cortex. Despite the availability of multimodality imaging, the epileptogenic zone is not determined solely by a single imaging modality. Evidence and experience have shown that concordance of results from clinical, electrophysiologic, and neuroimaging studies is needed to identify the epileptogenic zone accurately. With modern techniques in image processing, multimodality imaging can integrate the location of abnormal electroencephalographic, structural, and functional imaging foci on a "map" of the patient's brain. Computer image-guided surgery allows surgically exact implantation of intracranial electrodes and resection of abnormal structural or functional imaging foci. These techniques decrease the risk of morbidity associated with epilepsy surgery and enhance the probability of postsurgical seizure control.

Cortical dysplasia and epilepsy: functional imaging using single photon emission computed tomography and positron emission tomography

Functional imaging using single photon emission CT and positron emission tomography have made important contributions to the evaluation of patients with medically intractable epilepsy and cortical dysplasia by identifying patients who previously were not considered surgical candidates. This article reviews the role of functional imaging in the presurgical evaluation of this patient population.

The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery

Radiation necrosis and recurrent brain tumor have similar symptoms and are indistinguishable on both magnetic resonance imaging (MRI) and computed tomograph scans. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been proposed as a diagnostic alternative, particularly when co-registered with MRI. We studied 47 patients with brain tumors treated with stereotactic radiosurgery and followed with FDG PET. For all tumor types, the sensitivity of FDG PET for diagnosing tumor was 75% and the specificity was 81%. For brain metastasis without MRI co-registration, FDG PET had a sensitivity of 65% and a specificity of 80%. For brain metastasis with MRI co-registration, FDG PET had a sensitivity of 86% and specificity of 80%. MRI co-registration appears to improve the sensitivity of FDG PET, making it a useful modality to distinguish between radiation necrosis and recurrent brain metastasis.

Applications of positron emission tomography in neurosurgery: past, present, and future

Any novel technological innovation is dependent more on the ingenuity of its users than its inherent properties and potential flaws. Positron emission tomography (PET) is unique in this regard because the limitations of this modality are defined by the ability of its users to identify tracers that will aid in the diagnosis of intracerebral processes. The limitations of PET scanning lay in the extent of tissue resolution and in the currently relatively small number centers equipped to perform PET scanning.

In this issue of Neurosurgical Focus, various applications of PET scanning are detailed. The traditional use of this technology in neurosurgery has been to determine the metabolic nature of cerebral neoplastic lesions so as to help differentiate neoplastic from benign or infectious processes. This determination, however, has not been foolproof, and the technique has been further refined to maximize diagnostic yield.

Nonetheless, the utility of PET scanning continues to grow. New applications have allowed for the precise measurements of cerebral blood flow, helping the neuroscientist understand the functional organization of cortex, the pathophysiology of normal-pressure hydrocephalus, and changes in cerebral blood flow following traumatic injury. Other radiotracers such as fluorodopa allow assessment of the metabolic state of cerebral tissue transplants in restorative neurosurgical procedures.

In this introduction, all of these issues will be considered, and a historical perspective and the potential future uses of this technology will be provided. Technology moves so quickly that new instruments are routinely introduced. The authors will try to assess what properties, in the 25-year history of PET scanning, will need to be improved to keep it as a cutting-edge technology and expand its clinical role.

The functional neuroanatomy and long-term reproducibility of brain activation associated with a simple finger tapping task in older healthy volunteers: a serial PET study

We examined long-term reproducibility of the functional organization of the brain associated with a simple finger tapping movement using positron emission tomography (PET). Repeat measurements of regional cerebral blood flow were obtained in 10 individuals, ages 35 to 82 years (mean 52 years), at scanning sessions separated by 6 months. Although the functional neuroanatomy of hand movements has previously been investigated with PET by a number of groups, none has reported systematic investigation of the consistency of brain activation over an extended time. As expected, we found significant activation in the left precentral gyrus [Talairach coordinate (-32, -34, 52)], postcentral gyrus (-22, -48, 56), and supplementary motor area (SMA) (-2, -18, 52) at the initial study, consistent with previous studies in younger subjects. For the follow-up study we also found significant activation in the left precentral (-36, -28, 52) and postcentral (-28, -36, 52) gyri and in the SMA (2, -16, 56). Our group results demonstrate consistent anatomical location and extent of motor activation over time. More importantly, analysis of individuals confirmed the presence of consistent sites of activation in primary sensorimotor cortex and SMA over the 6-month interval in most subjects. A high degree of consistency in location of activation in the group, and within individuals, over time suggests that changes in loci of activation may be confidently monitored using the PET method. Evidence of individual differences in extent of activation over time highlights the need for caution when interpreting similar changes in patient studies.

Positron emission tomography in pediatric neurology

Positron emission tomography (PET) is an accurate and relatively noninvasive way of studying brain activity using systemically administered tracers labeled with positron emitting isotopes. In pediatric neurology, it has great scope not only to elucidate the complexities of the developing brain but also to understand disease processes and characterize biological risk factors. Its greatest clinical utility lies in the field of epilepsy where it is used (in patients with intractable partial epilepsy) to localize epileptogenic foci for surgical resection. In addition, functional brain mapping using PET is increasingly being used to reliably and accurately identify speech and sensory-motor areas to minimize postoperative morbidity. PET is also useful in evaluating neurodegenerative disorders and cognitive abnormalities when magnetic resonance imaging scans are unrevealing. The technology continues to progress rapidly through improvements in imaging and radiopharmacology with potential applications in neurooncology, cerebral vascular disease, and metabolic diseases.